Celia Oreja-Guevara

28PUBLICATIONS
163CO-AUTHORS
PharmacogenomicsNeurology and neuromuscular diseasesRegenerative medicine (incl. stem cells)Molecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 15, 2026
Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

|Jul 13, 2026
Long-Term Ravulizumab Efficacy and Safety in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Final CHAMPION-NMOSD Results.

|Jun 24, 2026
From options to decisions: an innovative model for treatment sequencing in relapsing-remitting multiple sclerosis.

|Jun 22, 2026
Efficacy and Safety of Patients With Relapsing Multiple Sclerosis Switching to Ocrelizumab Due to Suboptimal Treatment Response: Results of the 4-Year CASTING-LIBERTO Trial.

|Nov 05, 2025
Guiding Multiple Sclerosis Care: An Update to the 2013 Consensus Statement from the MS in the 21st Century Steering Group.

Raed Alroughani, Elisabeth G Celius, Helen Gray

|Sep 19, 2025
Twenty years of natalizumab in multiple sclerosis: lessons learned and future outlook.

Luisa Klotz, Thomas Berger, Wallace J Brownlee

Pageof 5

Frequent Collaborators

3 joint publications

Christine Lebrun-Frénay

3 joint publications

Massimo Filippi

3 joint publications

Tjalf Ziemssen

3 joint publications

Mar Tintoré